INTERNATIONAL PATENT: ACCRO BIOSCIENCE (HK) LIMITED, 爱科诺生物医药（香港）有限公司 FILES APPLICATION FOR "COMPOUND HAVING DUAL DEGRADATION ACTIVITY AGAINST IRAK4 AND FLT3 PROTEINS, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE THEREOF"

GENEVA, June 30 -- ACCRO BIOSCIENCE (HK) LIMITED (Room 2808, 28/F Wu Chung House, 213 Queen's Road East, Wan ChaiHong Kong), 爱科诺生物医药（香港）有限公司 (中国香港特别行政区湾仔皇后大道东213号胡忠大厦28楼2808室) filed a patent application (PCT/CN2024/139964) for "COMPOUND HAVING DUAL DEGRADATION ACTIVITY AGAINST IRAK4 AND FLT3 PROTEINS, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF" on Dec 17, 2024. With publication no. WO/2025/130871, the details related to the patent application was published on Jun...